secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001193125-26-103053
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus Therapeutics raises ~$673.5M in public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering of 7,313,582 shares at $81.00/share and pre-funded warrants for 402,468 shares at $80.999/share.
- Underwriters exercised in full option to purchase additional 1,157,407 shares on March 11, 2026.
- Net proceeds expected to be approximately $673.5 million after underwriting discounts and expenses.
- Offering expected to close March 12, 2026; securities offered under shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000119312526103053/0001193125-26-103053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000119312526103053/d43448d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-103053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer